Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

581 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Towards routine proteome profiling of FFPE tissue: insights from a 1,220-case pan-cancer study.
Tüshaus J, Eckert S, Schliemann M, Zhou Y, Pfeiffer P, Halves C, Fusco F, Weigel J, Hönikl L, Butenschön V, Todorova R, Rauert-Wunderlich H, The M, Rosenwald A, Heinemann V, Holch J, Steiger K, Delbridge C, Meyer B, Weichert W, Mogler C, Kuhn PH, Kuster B. Tüshaus J, et al. Among authors: heinemann v. EMBO J. 2024 Nov 18. doi: 10.1038/s44318-024-00289-w. Online ahead of print. EMBO J. 2024. PMID: 39558110 Free article.
Proteomics uncover EPHA2 as a potential novel therapeutic target in colorectal cancer cell lines with acquired cetuximab resistance.
Torlot L, Jarzab A, Albert J, Pók-Udvari Á, Stahler A, Holch JW, Gerlinger M, Heinemann V, Klauschen F, Kirchner T, Kumbrink J, Küster B, Jung A. Torlot L, et al. Among authors: heinemann v. J Cancer Res Clin Oncol. 2023 Feb;149(2):669-682. doi: 10.1007/s00432-022-04416-0. Epub 2022 Nov 19. J Cancer Res Clin Oncol. 2023. PMID: 36401637 Free PMC article.
EMT-Related Genes Have No Prognostic Relevance in Metastatic Colorectal Cancer as Opposed to Stage II/III: Analysis of the Randomised, Phase III Trial FIRE-3 (AIO KRK 0306; FIRE-3).
Pretzsch E, Heinemann V, Stintzing S, Bender A, Chen S, Holch JW, Hofmann FO, Ren H, Bösch F, Küchenhoff H, Werner J, Angele MK. Pretzsch E, et al. Among authors: heinemann v. Cancers (Basel). 2022 Nov 14;14(22):5596. doi: 10.3390/cancers14225596. Cancers (Basel). 2022. PMID: 36428688 Free PMC article.
The Liver Tumor Segmentation Benchmark (LiTS).
Bilic P, Christ P, Li HB, Vorontsov E, Ben-Cohen A, Kaissis G, Szeskin A, Jacobs C, Mamani GEH, Chartrand G, Lohöfer F, Holch JW, Sommer W, Hofmann F, Hostettler A, Lev-Cohain N, Drozdzal M, Amitai MM, Vivanti R, Sosna J, Ezhov I, Sekuboyina A, Navarro F, Kofler F, Paetzold JC, Shit S, Hu X, Lipková J, Rempfler M, Piraud M, Kirschke J, Wiestler B, Zhang Z, Hülsemeyer C, Beetz M, Ettlinger F, Antonelli M, Bae W, Bellver M, Bi L, Chen H, Chlebus G, Dam EB, Dou Q, Fu CW, Georgescu B, Giró-I-Nieto X, Gruen F, Han X, Heng PA, Hesser J, Moltz JH, Igel C, Isensee F, Jäger P, Jia F, Kaluva KC, Khened M, Kim I, Kim JH, Kim S, Kohl S, Konopczynski T, Kori A, Krishnamurthi G, Li F, Li H, Li J, Li X, Lowengrub J, Ma J, Maier-Hein K, Maninis KK, Meine H, Merhof D, Pai A, Perslev M, Petersen J, Pont-Tuset J, Qi J, Qi X, Rippel O, Roth K, Sarasua I, Schenk A, Shen Z, Torres J, Wachinger C, Wang C, Weninger L, Wu J, Xu D, Yang X, Yu SC, Yuan Y, Yue M, Zhang L, Cardoso J, Bakas S, Braren R, Heinemann V, Pal C, Tang A, Kadoury S, Soler L, van Ginneken B, Greenspan H, Joskowicz L, Menze B. Bilic P, et al. Among authors: heinemann v. Med Image Anal. 2023 Feb;84:102680. doi: 10.1016/j.media.2022.102680. Epub 2022 Nov 17. Med Image Anal. 2023. PMID: 36481607 Free PMC article.
Fluoropyrimidine-induced hand-foot syndrome and cardiotoxicity: recommendations for the use of the oral fluoropyrimidine S-1 in metastatic colorectal cancer.
Punt CJA, Heinemann V, Maughan T, Cremolini C, Van Cutsem E, McDermott R, Bodoky G, André T, Osterlund P, Teske AJ, Pfeiffer P. Punt CJA, et al. Among authors: heinemann v. ESMO Open. 2023 Apr;8(2):101199. doi: 10.1016/j.esmoop.2023.101199. Epub 2023 Apr 3. ESMO Open. 2023. PMID: 37018874 Free PMC article.
Implementing precision oncology for sarcoma patients: the CCCLMUmolecular tumor board experience.
Berclaz LM, Burkhard-Meier A, Lange P, Di Gioia D, Schmidt M, Knösel T, Klauschen F, von Bergwelt-Baildon M, Heinemann V, Greif PA, Westphalen CB, Heinrich K, Lindner LH. Berclaz LM, et al. Among authors: heinemann v. J Cancer Res Clin Oncol. 2023 Nov;149(15):13973-13983. doi: 10.1007/s00432-023-05179-y. Epub 2023 Aug 5. J Cancer Res Clin Oncol. 2023. PMID: 37542550 Free PMC article.
Identification of a gene expression signature associated with brain metastasis in colorectal cancer.
Michl M, Taverna F, Woischke C, Li P, Klauschen F, Kirchner T, Heinemann V, von Bergwelt-Baildon M, Stahler A, Herold TM, Jurinovic V, Engel J, Kumbrink J, Neumann J. Michl M, et al. Among authors: heinemann v. Clin Transl Oncol. 2024 Aug;26(8):1886-1895. doi: 10.1007/s12094-024-03408-5. Epub 2024 Mar 17. Clin Transl Oncol. 2024. PMID: 38558282 Free PMC article.
Cancer of unknown primary (CUP) through the lens of precision oncology: a single institution perspective.
Weiss L, Heinrich K, Zhang D, Dorman K, Rühlmann K, Hasselmann K, Klauschen F, Kumbrink J, Jung A, Rudelius M, Mock A, Ormanns S, Kunz WG, Roessler D, Beyer G, Corradini S, Heinzerling L, Haas M, von Bergwelt-Baildon M, Boeck S, Heinemann V, Westphalen CB. Weiss L, et al. Among authors: heinemann v. J Cancer Res Clin Oncol. 2023 Sep;149(11):8225-8234. doi: 10.1007/s00432-023-04741-y. Epub 2023 Apr 16. J Cancer Res Clin Oncol. 2023. PMID: 37062035 Free PMC article.
Patient eligibility for trials with imaging response assessment at the time of molecular tumor board presentation.
Mansour N, Heinrich K, Zhang D, Winkelmann M, Ingenerf M, Gold L, Klambauer K, Rudelius M, Klauschen F, von Bergwelt-Baildon M, Ricke J, Heinemann V, Westphalen CB, Kunz WG. Mansour N, et al. Among authors: heinemann v. Cancer Imaging. 2024 Jun 7;24(1):70. doi: 10.1186/s40644-024-00708-5. Cancer Imaging. 2024. PMID: 38849902 Free PMC article.
581 results